CD20-positive multiple myeloma - Differential expression of cyclins D1 and D2 suggests a heterogeneous disease

British Journal of Haematology

Volumn 149, Issue 1, 2010, Pages 156-159

  Quinn, John ^a   Percy, Laura ^a   Glassford, Janet ^a   Somana, Kathy ^b   Rodriguez Justo, Manuel ^c   Yong, Kwee ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CD20; Cyclin D; Myeloma

Indexed keywords

ANTINEOPLASTIC AGENT; CD20 ANTIGEN; CD56 ANTIGEN; CYCLIN D1; CYCLIN D2; RITUXIMAB; SYNDECAN 1;

ADULT; AGED; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CANCER PATIENT; CANCER SURVIVAL; CELLULAR DISTRIBUTION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELOMA CELL; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD20; CYCLIN D1; CYCLIN D2; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM PROTEINS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77949404019     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.08030.x     Document Type: Letter

References (10)

1. Bergsagel, P.L., Kuehl, W.M., Zhan, F., Sawyer, J., Barlogie, B. & Shaughnessy, J. (2005) Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood, 106, 296-303.
2. Ely, S., Di Liberto, M., Niesvizky, R., Baughn, L.B., Cho, H.J., Hatada, E.N., Knowles, D.M., Lane, J. & Chen-Kiang, S. (2005) Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma. Cancer Research, 65, 11345-11353.
3. Kapoor, P., Greipp, P.T., Morice, W.G., Rajkumar, S.V., Witzig, T.E. & Greipp, P.R. (2008) Anti-CD20 monoclonal antibody therapy in multiple myeloma. British Journal of Haematology, 141, 135-148.
4. Mateo, G., Castellanos, M., Rasillo, A., Gutiérrez, N.C., Montalbán, M.A., Martín, M.L., Hernández, J.M., López-Berges, M.C., Montejano, L., Bladé, J., Mateos, M.V., Sureda, A., De la Rubia, J., Díaz-Mediavilla, J., Pandiella, A., Lahuerta, J.J., Orfao, A. & San Miguel, J.F. (2005) Genetic abnormalities and patterns of antigenic expression in multiple myeloma. Clinical Cancer Research, 15, 3661-3667.
5. Matsui, W., Wang, Q., Barber, J.P., Brennan, S., Smith, B.D., Borrello, I., McNiece, I., Lin, L., Ambinder, R.F., Peacock, C., Watkins, D.N., Huff, C.A. & Jones, R.J. (2008) Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Research, 68, 190-197.
6. Moreau, P., Facon, T., Leleu, X., Morineau, N., Huyghe, P., Harousseau, J.L., Bataille, R. & Avet-Loiseau, H. (2002) Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy. Blood, 100, 1579-1583.
7. Robillard, N., Avet-Loiseau, H., Garand, R., Moreau, P., Pineau, D., Rapp, M.J., Harousseau, J.L. & Bataille, R. (2003) CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma. Blood, 102, 1070-1071.
8. Sahara, N., Takeshita, A., Shigeno, K., Fujisawa, S., Takeshita, K., Naito, K., Ihara, M., Ono, T., Tamashima, S., Nara, K., Ohnishi, K. & Ohno, R. (2002) Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma. British Journal of Haematology, 117, 882-885.
9. San Miguel, J.F., González, M., Gascón, A., Moro, M.J., Hernández, J.M., Ortega, F., Jimenez, R., Guerras, L., Romero, M. & Casanova, F. (1991) Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Castellano-Leones (Spain) Cooperative Group for the Study of Monoclonal Gammopathies. British Journal of Haematology, 1991, 77.
10. Zhan, F., Huang, Y., Colla, S., Stewart, J.P., Hanamura, I., Gupta, S., Epstein, J., Yaccoby, S., Sawyer, J., Burington, B., Anaissie, E., Hollmig, K., Pineda-Roman, M., Tricot, G., van Rhee, F., Walker, R., Zangari, M., Crowley, J., Barlogie, B. & Shaughnessy, J.D. Jr. (2006) The molecular classification of myeloma. Blood, 108, 2020-2028.